Stock Track | GOFINTECH QUANT Soars 5.10% Intraday on Strategic MOU with MedGraph Bio for Quantum Computing Expansion

Stock Track
Yesterday

GOFINTECH QUANT's stock price surged 5.10% during intraday trading on Monday, reflecting significant investor interest in the company's latest strategic development.

The sharp rise follows the company's announcement of a strategic cooperation memorandum of understanding (MOU) with MedGraph Bio (Suzhou) Life Science Technology Co., Ltd. The partnership involves a milestone-based licensing model across three key areas: asset licensing and acquisition of MedGraph Bio's quantum computing drug discovery systems (including QureGen AI and TyxonQ platforms), co-launching a quantum frontier technology investment fund targeting biopharmaceuticals and advanced materials, and jointly establishing a quantum computing center in Hong Kong focused on application R&D.

The board believes this collaboration will enhance the company's technological competitiveness in the quantum-AI convergence era and diversify its potential revenue streams, marking a strategic expansion into quantum AI-driven drug discovery.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10